CERE Annual ROE
-64.24%
+3.20%+4.74%
31 December 2023
Summary:
As of January 19, 2025, CERE annual return on equity is -64.24%, with the most recent change of +3.20% (+4.74%) on December 31, 2023. During the last 3 years, it has fallen by -24.67% (-62.35%).CERE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERE Quarterly ROE
-98.94%
+1.20%+1.20%
31 March 2024
Summary:
As of January 19, 2025, CERE quarterly return on equity is -98.94%, with the most recent change of +1.20% (+1.20%) on March 31, 2024. Over the past year, it has increased by +0.78% (+0.78%).CERE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERE ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.7% | +0.8% |
| 3 y3 years | -62.4% | -106.3% |
| 5 y5 years | +61.1% | -106.3% |
CERE ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +65.0% | +106.3% |
Cerevel Therapeutics Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -98.94%(-1.2%) |
| Dec 2023 | -64.24%(-4.7%) | -100.14%(+0.4%) |
| Sept 2023 | - | -99.72%(+19.9%) |
| June 2023 | - | -83.19%(+7.8%) |
| Mar 2023 | - | -77.15%(+15.2%) |
| Dec 2022 | -67.44% | -66.99%(+13.7%) |
| Sept 2022 | - | -58.94%(+14.9%) |
| June 2022 | - | -51.30%(+6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -47.97%(-2.0%) |
| Dec 2021 | -38.94%(-1.6%) | -48.94%(+1.1%) |
| Sept 2021 | - | -48.43%(-20.3%) |
| June 2021 | - | -60.79%(+17.2%) |
| Mar 2021 | - | -51.86%(-10.2%) |
| Dec 2020 | -39.57%(-76.0%) | -57.73%(-30.8%) |
| Sept 2020 | - | -83.43% |
| Dec 2019 | -164.98% | - |
FAQ
- What is Cerevel Therapeutics Holdings annual return on equity?
- What is the all time high annual ROE for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual ROE year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly ROE year-on-year change?
What is Cerevel Therapeutics Holdings annual return on equity?
The current annual ROE of CERE is -64.24%
What is the all time high annual ROE for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual return on equity is -38.94%
What is Cerevel Therapeutics Holdings annual ROE year-on-year change?
Over the past year, CERE annual return on equity has changed by +3.20% (+4.74%)
What is Cerevel Therapeutics Holdings quarterly return on equity?
The current quarterly ROE of CERE is -98.94%
What is the all time high quarterly ROE for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly return on equity is -47.97%
What is Cerevel Therapeutics Holdings quarterly ROE year-on-year change?
Over the past year, CERE quarterly return on equity has changed by +0.78% (+0.78%)